Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Université Laval manages a diverse patent portfolio with 7 pending office actions currently under review. These applications are categorized within the Biotechnology & Pharmaceuticals technology area. The prosecution landscape for this institution is notably broad, as the pending actions are distributed across 7 distinct art units. This variety suggests that the university is pursuing a wide range of biological or pharmaceutical innovations rather than a single narrow technology.
The institutional strategy involves significant examiner diversity, with distinct examiners assigned to the matters. FRANKLIN, JODI COHEN is the busiest examiner for the portfolio, though they are responsible for only 1 pending office action. This ratio where each examiner handles a single matter indicates that no individual examiner has a dominant influence over the current portfolio. For a practitioner, this necessitates a highly individualized approach to each application, as there is no overlap in the personnel or specific art units handling the institution's active files. The presence of 1 pending action per examiner ensures that the institution must navigate a wide array of individual office perspectives.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 1 (14%) |
| Multi-statute (no §101) | 5 (71%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRANKLIN, JODI COHEN | 1 | 61.5% | +24.1% |
| IANNUZO, NATALIE NMN | 1 | 12.5% | +71.4% |
| HOFFMAN, ALEXANDER JOSEPH | 1 | — | — |
| IQBAL, SYED TAHA | 1 | 79.9% | +21.3% |
| HUSSAIN, MISHAL ZAHRA | 1 | 67.3% | +37.0% |
| KATAKAM, SUDHAKAR | 1 | 74.7% | +23.3% |
| NGUYEN, LAUREN | 1 | 54.8% | +34.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17783539 | ELECTRODE STRUCTURE FOR CREATING ELECTRICAL POTENTIAL GRADIENT | NGUYEN, LAUREN | 29d |
| 18276598 | A Facial Mask Assembly Dispensing a Protective Laminar Airflow | HUSSAIN, MISHAL ZAHRA | 62d |
| 18717027 | BIOMARKERS FOR PROGNOSIS OF EARLY ONSET PREECLAMPSIA | IANNUZO, NATALIE NMN | — |
| 18563723 | METHODS AND KITS FOR DIAGNOSING SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES | HOFFMAN, ALEXANDER JOSEPH | — |
| 18382191 | BISMUTH-DOPED GERMANOSILICATE FIBER FOR E AND S BAND AMPLIFICATION | IQBAL, SYED TAHA | — |
| 18087433 | PROCESS FOR THE LINEAR SYNTHESIS OF GRAM-POSITIVE CLASS II BACTERIOCINS AND COMPOSITIONS AND USES THEREOF | KATAKAM, SUDHAKAR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17783539 | ELECTRODE STRUCTURE FOR CREATING ELECTRICAL POTENTIAL GRADIENT | NGUYEN, LAUREN | 29d |
| 18276598 | A Facial Mask Assembly Dispensing a Protective Laminar Airflow | HUSSAIN, MISHAL ZAHRA | 62d |
| 18838855 | METHOD FOR TREATING THE SURFACE OF AN IONIC AMORPHOUS MATERIAL TO CONTROL THE ORIENTATION OF LIQUID CRYSTALS, METHOD FOR MANUFACTURING MULTI-DOMAIN ALIGNMENT LIQUID CRYSTAL CELLS | FRANKLIN, JODI COHEN | — |
| 18717027 | BIOMARKERS FOR PROGNOSIS OF EARLY ONSET PREECLAMPSIA | IANNUZO, NATALIE NMN | — |
| 18382191 | BISMUTH-DOPED GERMANOSILICATE FIBER FOR E AND S BAND AMPLIFICATION | IQBAL, SYED TAHA | — |
| 18087433 | PROCESS FOR THE LINEAR SYNTHESIS OF GRAM-POSITIVE CLASS II BACTERIOCINS AND COMPOSITIONS AND USES THEREOF | KATAKAM, SUDHAKAR | — |
| Art Unit | Apps |
|---|---|
| 1741 | 1 |
| 1653 | 1 |
| 1677 | 1 |
| 1736 | 1 |
| 3785 | 1 |
| 1658 | 1 |
| 2871 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18838855 | METHOD FOR TREATING THE SURFACE OF AN IONIC AMORPHOUS MATERIAL TO CONTROL THE ORIENTATION OF LIQUID CRYSTALS, METHOD FOR MANUFACTURING MULTI-DOMAIN ALIGNMENT LIQUID CRYSTAL CELLS | FRANKLIN, JODI COHEN | 1741 | §103 | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18717027 | BIOMARKERS FOR PROGNOSIS OF EARLY ONSET PREECLAMPSIA | IANNUZO, NATALIE NMN | 1653 | §101§102§103§112 | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18563723 | METHODS AND KITS FOR DIAGNOSING SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES | HOFFMAN, ALEXANDER JOSEPH | 1677 | §103§112 | Non-Final OA | — | Pending | Nov 22, 2023 |
| 18382191 | BISMUTH-DOPED GERMANOSILICATE FIBER FOR E AND S BAND AMPLIFICATION | IQBAL, SYED TAHA | 1736 | §102§103 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18276598 | A Facial Mask Assembly Dispensing a Protective Laminar Airflow | HUSSAIN, MISHAL ZAHRA | 3785 | §102§103§112 | Non-Final OA | 62d | Pending | Aug 09, 2023 |
| 18087433 | PROCESS FOR THE LINEAR SYNTHESIS OF GRAM-POSITIVE CLASS II BACTERIOCINS AND COMPOSITIONS AND USES THEREOF | KATAKAM, SUDHAKAR | 1658 | §103§112 | Non-Final OA | — | Pending | Dec 22, 2022 |
| 17783539 | ELECTRODE STRUCTURE FOR CREATING ELECTRICAL POTENTIAL GRADIENT | NGUYEN, LAUREN | 2871 | §103§112 | Non-Final OA | 29d | Pending | Jun 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial